Company Overview

Update
Founded:
2007
Headquarters:
Sheffield
Funding:
$1.30M
Categories:
Biotechnology

Absynth Biologics develops treatments to prevent immunological diseases and therapies to combat bacterial infections.

Description

Update

Absynth Biologics has been created with the initial goal of developing immunological prophylaxis and therapy to combat bacterial infections. Absynth’s strategy is to exploit the characterisation of carefully selected novel proteins Staphylococcus aureus (S. aureus)in bacteria as immunological targets.

Current Team (2)

Update

Funding Rounds (1) - $1.30M

Update

Investors (2)

Update
  • A348f38b3f9d5cd0b29ec28b1e66911e

    Fusion IP

    Fusion IP owns the rights to 100% of university-owned research generated at two of the UK's..
  • 2437abc9b8d370018069779b39b92eba

    The North West Fund

    The North West Fund is an evergreen investment fund established to provide debt and equity funding..

Offices/Locations (1)

Update
  • Office

    The Bioincubator

    40 Leavygreave Road

    Sheffield, S3 7RD

    GBR

Images (1)

Update
  • 717b4036689b8198c448f14192f68bc3